Pharmaceutical

Innovation in the pharmaceutical industry has a widespread impact that ignites competition and drives conflict in one of the most scrutinized areas of life sciences. WIT represents highly credentialed experts who know the pharmaceutical industry and can address issues regarding the research, development, and manufacturing of drugs and medications.

Pharmaceutical companies face constant challenges, including protecting intellectual property and navigating evolving government regulations. Our pharmaceutical expert team is comprised of world-class academics, industry executives, and former government regulators who were carefully selected for their knowledge, experience, and ability to communicate effectively.

Trends

FDA-Regulated Drugs and Devices

WIT represents the most qualified experts for litigation involving the science, manufacturing, and distribution of FDA-regulated drugs, chemical components, and medical devices.

Learn More

Up Next: Drug and Vaccine Development

Drug and Vaccine Development

The accelerated pace of drug and vaccine development will create many areas of dispute for pharmaceutical companies. From regulatory enforcement actions to intellectual property litigation, WIT has leading testifying experts in relevant fields.

Learn More

Up Next: FDA-Regulated Drugs and Devices

Our Experts

Our focus on the pharmaceutical industry allows us to bring together independent testifying experts under one virtual roof to address issues in complex legal disputes involving:

Clinical Trials
Trial Design, Data Analysis
Drug Safety
Diversion Prevention, Counterfeit Detection
Drug Types
Biologics, Small Molecules, OTC Drugs
Industry Landscape
Market Trends, Regulatory Impact

IP and Compliance
Patent Disputes, Regulatory Adherence
Manufacturing
cGMP, FDA Compliance
Marketing and Sales
Labeling, Pricing Strategies

Related Insights

Case Study- Life Sciences

Case Study: Pharmaceutical Experts Needed for ANDA Dispute Concerning Cancer Drugs

The defendant approached WIT to provide two pharmaceutical experts with advanced knowledge in drug composition, albumin-paclitaxel binding, and nanoparticle delivery. Read the case study to learn how WIT was able to meet the expert need.

Report

A National Study of Community Attitudes Toward Pharmaceutical Companies

WIT commissioned the DOAR Research Center to conduct a national study of community attitudes toward pharmaceutical companies and several issues suspected of creating bias. Learn more about their findings.

All Insights

What are some of our other areas of focus in Life Sciences?

Learn More